Table: Delta-Fly Pharma -2023/24 parent results
May 15 (Reuters)-
Delta-Fly Pharma, Inc.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2024 Mar 31, 2023 Mar 31, 2025 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
(-100.0 pct)
Operating loss 1.40 loss 1.32 loss 1.82
Recurring loss 1.43 loss 1.33 loss 1.83
Net loss 1.43 loss 1.33 loss 1.83
EPS loss 198.78 yen loss 234.51 yen loss 222.34 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - Delta-Fly Pharma, Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4598.T